Hypergravity modulates vitamin D receptor target gene mRNA expression in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 3, 2009, Pages

  Ishizawa, Michiyasu ^a   Iwasaki, Ken Ichi ^a   Kato, Shigeaki ^b   Makishima, Makoto ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hypergravity; Kidney; Transcription; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D 1ALPHA HYDROXYLASE; 25 HYDROXYVITAMIN D 24 HYDROXYLASE; ALFACALCIDOL; CALCITRIOL; MESSENGER RNA; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM METABOLISM; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION REGULATION; GENE FUNCTION; GRAVITY; KIDNEY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STARVATION; STRESS; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERGRAVITY; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CALCITRIOL; RNA, MESSENGER; VITAMIN D;

EID: 69049084737     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00168.2009     Document Type: Article

References (32)

1. 3 in humans. J Clin Endocrinol Metab 89: 5387-5391, 2004.
2. Carmeliet G, Nys GUY, Bouillon R. Microgravity reduces the differentiation of human osteoblastic MG-63 cells. J Bone Miner Res 12: 786-794, 1997.
3. Cui M, Zhao Y, Hance KW, Shao A, Wood RJ, Fleet JC. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2. J Cell Physiol 219: 132-142, 2009.
4. 3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J Biol Chem 277: 29643-29653, 2002.
5. Hardwick JP. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 75: 2263-2275, 2008.
6. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998.
7. Heer M, Kamps N, Biener C, Korr C, Boerger A, Zittermann A, Stehle P, Drummer C. Calcium metabolism in microgravity. Eur J Med Res 4: 357-360, 1999.
8. Hegardt FG. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J 338: 569-582, 1999.
9. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Mol Cell Endocrinol 215: 31-38, 2004.
10. Holick MF. Vitamin D deficiency. N Engl J Med 357: 266-281, 2007.
11. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80: 201-204, 1983.
12. 2 to calcitroic acid. J Cell Biochem 88: 282-285, 2003.
13. Ishizawa M, Matsunawa M, Adachi R, Uno S, Ikeda K, Masuno H, Shimizu M, Iwasaki K, Yamada S, Makishima M. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res 49: 763-772, 2008.
14. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 78: 1193-1231, 1998.
15. 3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265-266: 168-173, 2007.
16. Kita S, Iwasaki K, Onishi R, Fujisawa M, Kim H, Shibata S, Ito M. Bone metabolism and formation of mice bred in a 2 G environment. Adv Space Res 32: 1453-1457, 2003.
17. Kita S, Shibata S, Kim H, Otsubo A, Ito M, Iwasaki K. Dose-dependent effects of hypergravity on body mass in mature rats. Aviat Space Environ Med 77: 842-845, 2006.
18. 3 during spaceflight. Ann NY Acad Sci 1030: 121-124, 2004.
19. LeBlanc AD, Spector ER, Evans HJ, Sibonga JD. Skeletal responses to space flight and the bed rest analog: a review. J Musculoskelet Neuronal Interact 7: 33-47, 2007.
20. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238, 2002.
21. Makishima M, Yamada S. Targeting the vitamin D receptor: advances in drug discovery. Expert Opin Ther Pat 15: 1133-1145, 2005.
22. 3 in mouse kidney and intestine in vivo. J Biol Chem 282: 22344-22352, 2007.
23. Morita S, Nakamura H, Kumei Y, Shimokawa H, Ohya K, Shinomiya K. Hypergravity stimulates osteoblast phenotype expression: a therapeutic hint for disuse bone atrophy. Ann NY Acad Sci 1030: 158-161, 2004.
24. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687, 2005.
25. 3 is a preventive factor in the metastasis of lung cancer. Carcinogenesis 26: 429-440, 2005.
26. 3 analog, EB1089. Bone 31: 381-388, 2002.
27. 3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice. J Pharmacol Exp Ther 328: 564-570, 2009.
28. Shibata S, Kita S, Kim H, Ito M, Iwasaki K. Morphometric changes in vagal nerves of fourth generation mice passage-bred in a 2-G environment. Aviat Space Environ Med 75: 387-390, 2004.
29. Smith SM, Heer M. Calcium and bone metabolism during space flight. Nutrition 18: 849-852, 2002.
30. Smith SM, Wastney ME, Morukov BV, Larina IM, Nyquist LE, Abrams SA, Taran EN, Shih CY, Nillen JL, Davis-Street JE, Rice BL, Lane HW. Calcium metabolism before, during, and after a 3-mo space-flight: kinetic and biochemical changes. Am J Physiol Regul Integr Comp Physiol 277: R1-R10, 1999.
31. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16: 391-396, 1997.
32. 3. Mol Endocrinol 20: 1231-1247, 2006.